Litcius/Paper detail

Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF

Juan Antonio Requena-Ibáñez, Carlos G. Santos‐Gallego, Anderly Rodriguez-Cordero, Ariana P. Vargas-Delgado, Donna Mancini, Samantha Sartori, Farah Atallah-Lajam, Chiara Giannarelli, Frank Macaluso, Anuradha Lala, Javier Sanz, Valentı́n Fuster, Juan J. Badimón

2021JACC Heart Failure262 citationsDOI

Topics & Concepts

EmpagliflozinMedicineCardiologyInternal medicineHeart failureBenzhydryl compoundsIntensive care medicineDiabetes mellitusEndocrinologyType 2 diabetesOrganic chemistryChemistryEpoxyBisphenol ACardiovascular Disease and AdiposityCardiovascular Function and Risk FactorsCardiac Fibrosis and Remodeling
Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF | Litcius